Corey W Roush

Corey Roush's practice primarily focuses on antitrust and consumer protection litigation, white collar criminal defense, corporate governance and internal investigations, and other complex commercial litigation. Corey has worked with several online and high-tech companies, as well as a wide range of brick and mortar clients, on issues pertaining to mergers and acquisitions, joint ventures, health care, the defense industry, and intellectual property. He also routinely counsels clients on risk management and strategic planning, as well as complying with various federal and state laws and regulations, including the Sherman Act, the Federal Trade Commission (FTC) Act, the Anti-Kickback Statute, and the False Claims Act. Corey has represented clients in federal antitrust, consumer protection, intellectual property, and qui tam litigation cases in several district and appellate courts around the country, as well as in administrative hearings before the FTC. In addition, he has represented clients before the FTC, the Antitrust Division of the U.S. Department of Justice, and various attorneys general around the country. As lead counsel, Corey has a strong record having won several dismissals of cases at the motion to dismiss stage, as well as assisted in procuring favorable settlements of federal antitrust claims relating to patent misuse in the defense, aeronautics, and pharmaceutical industries. He has also assisted in the successful resolution of several other lawsuits in various industries. Through these representations, Corey has gained extensive experience in responding to administrative subpoenas, civil investigative demands, second requests, and other government requests for information, as well as responding to discovery requests. Corey has also worked at length with clients to successfully resolve civil and criminal investigations conducted by the government in antitrust, as well as other areas including the medical device and pharmaceutical industries. He also frequently conducts internal investigations for companies arising out of whistle-blower allegations, qui tam lawsuits, and other allegations of misconduct. Corey has published a number of articles on antitrust and other topics and has spoken on antitrust litigation and legislative issues. His published articles have appeared in MergerMarket, Healthcare Labor Reports, the National Law Journal, the Sixth Annual Internet Law Institute, the American Criminal Law Review, and the University of Dayton School of Law Law Review. He is also co-author of the Antitrust chapter of The Fundamentals of Live Sciences Law: Drugs, Devices and Biotech.